GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ascentage Pharma Group International (HKSE:06855) » Definitions » 5-Year Yield-on-Cost %

Ascentage Pharma Group International (HKSE:06855) 5-Year Yield-on-Cost % : 0.00 (As of May. 02, 2025)


View and export this data going back to 2019. Start your Free Trial

What is Ascentage Pharma Group International 5-Year Yield-on-Cost %?

Ascentage Pharma Group International's yield on cost for the quarter that ended in Dec. 2024 was 0.00.


The historical rank and industry rank for Ascentage Pharma Group International's 5-Year Yield-on-Cost % or its related term are showing as below:



HKSE:06855's 5-Year Yield-on-Cost % is not ranked *
in the Biotechnology industry.
Industry Median: 1.685
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of Ascentage Pharma Group International's 5-Year Yield-on-Cost %

For the Biotechnology subindustry, Ascentage Pharma Group International's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ascentage Pharma Group International's 5-Year Yield-on-Cost % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ascentage Pharma Group International's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Ascentage Pharma Group International's 5-Year Yield-on-Cost % falls into.


;
;

Ascentage Pharma Group International 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Ascentage Pharma Group International is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Ascentage Pharma Group International  (HKSE:06855) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Ascentage Pharma Group International 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Ascentage Pharma Group International's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Ascentage Pharma Group International Business Description

Traded in Other Exchanges
Address
68 Xinqing Road, Suzhou Industrial Park, Jiangsu, Suzhou, CHN, 215000
Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.
Executives
Jpmorgan Chase & Co. 2201 Interest of corporation controlled by you
Takeda Pharmaceuticals International Ag 2101 Beneficial owner
Takeda Pharmaceuticals Company Limited 2201 Interest of corporation controlled by you
Gao Sharon Xia
Zhai Yifan
Yang Dajun
Wang Shaomeng
Li Ju-yun
Healthquest Pharma Limited
Guo Edward Ming
Ascentage Limited
South Dakota Trust Company Llc 2301 Trustee
Tian Yuan 2201 Interest of corporation controlled by you
Zhao Li 2202 Interest of your spouse
Xian Jin Zhi Zao Chan Ye Tou Zi Ji Jin You Xian He Huo 2201 Interest of corporation controlled by you

Ascentage Pharma Group International Headlines

No Headlines